Nanobodies can be used to detect atherosclerosis risk

04/9/2012 | MedPage Today (free registration)

French researchers have developed nanobodies that can attach to vascular cell adhesion molecule-1, which is linked to the development of atherosclerosis, according to a study published in Circulation Research. The nanobodies can be tagged with technetium-99m and imaged through SPECT, according to the study. Researchers said SPECT also identified human and mouse cross-reactive labeled VCAM-1, indicating that the nanobodies can be used in the clinical setting.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ